Case Report: Acute Fulminant Myocarditis and Cardiogenic Shock After Messenger RNA Coronavirus Disease 2019 Vaccination Requiring Extracorporeal Cardiopulmonary Resuscitation

South Korea, 29 October 2021, Frontiers in Cardiovascular Medicine


A previously healthy 38-year-old female received the BNT162b2-mRNA vaccine (Pfizer-BioNTech) 7 days prior to developing acute fulminant myocarditis, cardiac arrest (requiring 25 minutes of CPR and ECMO), global akinesia with severe left and right ventricular dysfunction (ejection fraction <10%) and marked edematous left ventricular (LV) wall thickening (13 mm).

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s